Session Details

Merck & Co., Inc. Satellite Symposium - Clinical and Functional Issues in Disease Modification of Alzheimer's Disease

Chairperson

Professor Graham Burrows

University of Melbourne, Austin Health

Australia

Disease modification versus symptom improvement: Issues in clinical diagnosis and assessment

Professor Siegfried Kasper, The University of Vienna, Austria

Do current therapies modify disease progression in Alzheimer's Disease?

Alan F Schatzberg, Stanford University School of Medicine, United States

Improving patient and caregiver burden through early disease modification

Professor Graham Burrows, University of Melbourne, Austin Health, Australia